These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26320779)

  • 1. Antibodies against heparin-protamine complexes: Effect and clinical relevance.
    Beckerman Z; Cohen O
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):974-5. PubMed ID: 26320779
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet-activating protamine-heparin-antibodies lead to higher protamine demand in patients undergoing cardiac surgery.
    Grieshaber P; Bakchoul T; Wilhelm J; Wagner A; Wollbrück M; Böning A; Sachs U
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):967-73.e1. PubMed ID: 26298870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass.
    Lee GM; Welsby IJ; Phillips-Bute B; Ortel TL; Arepally GM
    Blood; 2013 Apr; 121(15):2828-35. PubMed ID: 23422751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis.
    Bakchoul T; Zöllner H; Amiral J; Panzer S; Selleng S; Kohlmann T; Brandt S; Delcea M; Warkentin TE; Sachs UJ; Greinacher A
    Blood; 2013 Apr; 121(15):2821-7. PubMed ID: 23325832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass.
    Gruenwald CE; Manlhiot C; Chan AK; Crawford-Lean L; Foreman C; Holtby HM; Van Arsdell GS; Richards R; Moriarty H; McCrindle BW
    J Am Coll Cardiol; 2010 Nov; 56(22):1794-802. PubMed ID: 21087706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
    Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine?
    Gertler R; Wiesner G; Tassani-Prell P; Braun SL; Martin K
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):981-6. PubMed ID: 21315618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protamine-induced thrombocytopenia?
    Cuker A; Cines DB
    Blood; 2013 Apr; 121(15):2818-9. PubMed ID: 23580634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case 7--2001. Management during cardiopulmonary bypass of patients with presumed fish allergy.
    Mukadam ME; Pritchard P; Riddington D; Wilkes M; Graham TR; Horrow JC; Spiess BD
    J Cardiothorac Vasc Anesth; 2001 Aug; 15(4):512-9. PubMed ID: 11505358
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass.
    Kunz SA; Miles LF; Ianno DJ; Mirowska-Allen KL; Matalanis G; Bellomo R; Seevanayagam S
    Perfusion; 2018 Sep; 33(6):445-452. PubMed ID: 29544405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
    Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot validation of an individualised pharmacokinetic algorithm for protamine dosing after systemic heparinisation for cardiopulmonary bypass.
    Miles LF; Marchiori P; Falter F
    Perfusion; 2017 Sep; 32(6):481-488. PubMed ID: 28820026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy.
    Hofmann B; Bushnaq H; Kraus FB; Raspé C; Simm A; Silber RE; Ludwig-Kraus B
    Perfusion; 2013 Sep; 28(5):412-8. PubMed ID: 23625867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological features of antibodies to protamine inducing thrombocytopenia and thrombosis.
    Panzer S; Schiferer A; Steinlechner B; Drouet L; Amiral J
    Clin Chem Lab Med; 2015 Feb; 53(2):249-55. PubMed ID: 25153412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.
    Patel AA; White CM; Coleman CI
    Conn Med; 2007 Feb; 71(2):93-5. PubMed ID: 17393902
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence of antibodies to protamine sulfate/heparin complexes incardiac surgery patients and impact on platelet activation and clinical outcome.
    Pouplard C; Leroux D; Rollin J; Amiral J; May MA; Gruel Y
    Thromb Haemost; 2013 Jun; 109(6):1141-7. PubMed ID: 23636177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of heparin neutralization by protamine on restenosis after coronary stent implantation.
    Kaneda H; Suzuki J; Hosokawa G; Tanaka S; Hiroe Y; Saito S
    Int J Cardiol; 2005 Oct; 105(1):111-2. PubMed ID: 16207558
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal of anticoagulant activity of heparin and low molecular weight heparins by poly-l-lysine: A comparative 'in vitro' study versus protamine sulfate.
    Muralidharan-Chari V; Kim J; Mousa SA
    Thromb Res; 2017 Jul; 155():128-130. PubMed ID: 28538195
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin and protamine requirements of patients in chronic renal failure.
    Akpek EA; Dönmez A; Erol E; Sekerci S; Arslan G
    Transplant Proc; 1998 May; 30(3):805-6. PubMed ID: 9595106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.